131 related articles for article (PubMed ID: 9017423)
1. Modulation of erythropoietin delivery from engineered muscles in mice.
Bohl D; Heard JM
Hum Gene Ther; 1997 Jan; 8(2):195-204. PubMed ID: 9017423
[TBL] [Abstract][Full Text] [Related]
2. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles.
Naffakh N; Pinset C; Montarras D; Li Z; Paulin D; Danos O; Heard JM
Hum Gene Ther; 1996 Jan; 7(1):11-21. PubMed ID: 8825864
[TBL] [Abstract][Full Text] [Related]
3. Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.
Hamamori Y; Samal B; Tian J; Kedes L
Hum Gene Ther; 1994 Nov; 5(11):1349-56. PubMed ID: 7893806
[TBL] [Abstract][Full Text] [Related]
4. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
5. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
6. Regulation of N-acetylgalactosamine 4-sulfatase expression in retrovirus-transduced feline mucopolysaccharidosis type VI muscle cells.
Yogalingam G; Muller V; Hopwood JJ; Anson DS
DNA Cell Biol; 1999 Mar; 18(3):187-95. PubMed ID: 10098600
[TBL] [Abstract][Full Text] [Related]
7. Specificity of action of a herpes virus VP16/tetracycline-dependent trans-activator in mammalian cell cultures.
Magalini A; Ferrari F; Savoldi G; Ingrassia R; Albertini A; Pollio G; Patrone C; Maggi A; Di Lorenzo D
DNA Cell Biol; 1995 Aug; 14(8):665-71. PubMed ID: 7646813
[TBL] [Abstract][Full Text] [Related]
8. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette.
Hofmann A; Nolan GP; Blau HM
Proc Natl Acad Sci U S A; 1996 May; 93(11):5185-90. PubMed ID: 8643550
[TBL] [Abstract][Full Text] [Related]
9. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
Naffakh N; Henri A; Villeval JL; Rouyer-Fessard P; Moullier P; Blumenfeld N; Danos O; Vainchenker W; Heard JM; Beuzard Y
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3194-8. PubMed ID: 7724539
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
[TBL] [Abstract][Full Text] [Related]
11. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system.
Hwang JJ; Scuric Z; Anderson WF
J Virol; 1996 Nov; 70(11):8138-41. PubMed ID: 8892941
[TBL] [Abstract][Full Text] [Related]
12. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.
Hamamori Y; Samal B; Tian J; Kedes L
J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487
[TBL] [Abstract][Full Text] [Related]
13. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
[TBL] [Abstract][Full Text] [Related]
14. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts.
Bohl D; Naffakh N; Heard JM
Nat Med; 1997 Mar; 3(3):299-305. PubMed ID: 9055857
[TBL] [Abstract][Full Text] [Related]
15. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters.
Maxwell IH; Spitzer AL; Long CJ; Maxwell F
Gene Ther; 1996 Jan; 3(1):28-36. PubMed ID: 8929909
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
17. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
18. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Furth PA; St Onge L; Böger H; Gruss P; Gossen M; Kistner A; Bujard H; Hennighausen L
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9302-6. PubMed ID: 7937760
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
20. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen M; Bujard H
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5547-51. PubMed ID: 1319065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
